Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Grand Rounds
- Neuromodulation
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
11/15/2023
$0.00
Mental disorders arise from brain circuit dysfunctions, but most of our treatments target the whole brain rather than defined circuits. Deep brain stimulation (DBS) is a more circuit-directed approach that has done well in movement disorders but has very mixed results in randomized clinical trials for mental illness. Part of the difficulty is that psychiatric DBS is delivered in a trial-and-error fashion, without clear evidence that it engages the target circuits. I will discuss new strategies for developing biomarkers to guide that target engagement, centered around the idea of understanding how brain stimulation changes cognition and decision-making. We have identified ways in which DBS can augment top-down executive function and have linked those changes to cortical electrophysiology. In animals, we have developed new approaches to understand how those changes occur and how we can leverage them for clinical benefit. Taken together, these offer the prospect of a new generation of rationally designed brain stimulation therapies.
- Child & Adolescent
- Grand Rounds
- Well-Being
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
11/29/2023
$0.00
The Covid-19 pandemic and the resulting social and environmental changes exacerbated an already existing crisis of children’s mental health. Reports by researchers, clinicians, families, and youth have documented increasing rates of depression, anxiety, and suicidal behaviors among youth. The national declaration the children’s mental health emergency by AACAP, AAP and CHA called attention to worsening access to care that had existed prior to the pandemic. The pandemic also highlighted disparities in health care access and treatment, especially for minoritized populations and girls, and the impact of social determinants of health as major drivers for health outcomes, including mental health. Unprecedented national focus on children’s mental health, highlighted by the surgeon general’s report, provides opportunities for psychiatrists along with other mental health professionals to create mental health systems that will better serve our nation’s youth and families.
- Climate Psychology
- Grand Rounds
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
12/06/2023
$0.00
Climate change presents the mental health professions with profound challenges in responding to and preparing for acute and chronic, multifaceted, mental health needs in individual patients, families, communities and our larger society. Mental health professionals can be as disoriented as others in integrating the evolving realities of climate change and our multiple social crises. However, we do have understandings and skills that are pathways out of disorientation. This presentation will assist the clinician in being more comfortable and capable in responding to and working with climate change realities and climate change material in treatment. Particular attention will be paid to issues for adolescents, young adults, and parents and what is required for “containment” of climate-related experience. There will be emphasis on the public health aspects of our work and the requirement that we deeply understand our predicament, as we must now “skate to where the puck is going to be”.
- Anxiety/OCD
- Child & Adolescent
- Psychotherapy
- Workshop
- 3.00 ACEP NBCC clock hours
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Category I credits for Social Workers
- 3.00 Psychologists
- 3.00 MNA Contact Hours for Nurses
- 3.00 Participation
12/08/2023
$0.00
Obsessive-Compulsive Disorder (OCD) is a common and often debilitating mental health condition characterized by unwanted intrusive thoughts (obsessions) and repeated distress-reducing behaviors (compulsions). Frequently misunderstood, misdiagnosed, and mistreated, this series of lectures will demystify OCD and related disorders and the most effective protocols for helping those who suffer from them. Attendees new to or heavily experienced in treating OCD and related disorders will gain knowledge from multiple perspectives. This unique format features six lectures from top experts in the field, scheduled across three sessions over the Fall season. This series includes experts presenting on uncertainty acceptance in OCD treatment, sleep and OCD, process-based treatment of severe OCD and related disorders in for teens, similarities and differences in interventions for OCD and related disorders, current best practices for children and adolescents, and multimodal treatment of pediatric OCD at higher levels of care.
- Child & Adolescent
- Grand Rounds
- Psychopharmacology
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
12/13/2023
$0.00
This presentation will explore the relational aspects of psychopharmacological work with youth and families. While technical and scientific knowledge can be taught and examined during medical education, the therapeutic skills also known as “nonspecific” treatment factors or “common factors” are more elusive and harder to describe.
Differences in culture between the prescriber and the patient often lead to differing perspectives and, if not explored, can interfere with the treatment alliance and subsequently with treatment adherence and/or resistance. Cultural concordance is crucial to teach physicians how to appreciate the cultural background unique to each patient in a way that values and honors our similarities and our differences. In keeping with the adage, The formulation must always precede the prescription, recent work has highlighted the use of the DSM-5 Cultural Formulation Interview as an important tool to more fully understand a young person in the context of their daily life, as part of comprehensive treatment planning.
We propose that the term ‘med check’ is not only a misnomer that simply doesn’t exist in child and adolescent psychiatric treatment (as if the patient just comes to us wanting to ‘talk about their meds’), but more importantly it is a disservice to the nature and intention of our work with youth and families. For such time-limited visits where the medication issues are a primary focus, we propose the term, ‘brief pharmacotherapy visits’, which allows us to retain our role as therapists (as an inextricable part of psychopharmacology). An effective pharmacotherapy appointment necessitates the appreciation of many things that inform treatment, and thus pharmacotherapy decisions, including the intricacies of an individual’s culturally informed, biopsychosocial story. It has consistently been shown that strong therapeutic alliances between a patient and their mental health provider, as well as empathy demonstrated by the latter, lead to more positive clinical and functional outcomes- and thus to the primary goal of evaluating and promoting mental health and well-being.
- Grand Rounds
- Mood Disorders
- Psychiatric Illness
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
01/10/2024
$0.00
This talk will review the behavioral pharmacology and treatment of substance use disorders with psilocybin and other classic psychedelics (5HT2A agonists). Early research from the 1950s to 1970s investigated classic psychedelics, primarily LSD, in the treatment of alcoholism and cancer-related distress. Over the last 20 years research has once again investigated psychedelics in the treatment of psychiatric disorders including substance use disorders, cancer-related distress, and depression. This talk will provide a current description of this work as well as a vision for the future.
- Grand Rounds
- Mood Disorders
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
01/17/2024
$0.00
Unlike bipolar I disorder (BD I), which has been extensively studied and depicted in popular literature and on screen, bipolar II disorder (BD II) is poorly understood, underdiagnosed, and insufficiently treated. This has often resulted in an over 10-year delay in diagnosis. BD II is mistakenly described a “lesser form” of BD I, despite numerous studies showing comparable illness severity and risk of suicide in these two BD subtypes. Perhaps because of its under-recognition, treatment studies of BD II are limited, and too often results from studies of patients with BD I are simply applied to those with BD II with no direct evidence supporting this practice. BD II is an understudied and unmet treatment challenge in psychiatry. This talk will provide a broad overview of BD II including differential diagnosis, course of illness, suicide risk and evidence-based treatment options.
- Child & Adolescent
- Grand Rounds
- Mood Disorders
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
01/24/2024
$0.00
The differential diagnosis of children with severe emotional dysregulation now includes bipolar disorder. Yet, the diagnosis of mania can be difficult to make because of the developmentally different presentation and high rates of comorbidity. Distinguishing bipolar depression from unipolar depression can be difficult and mania and ADHD share many symptoms. This presentation will review the diagnosis of mania in children including research addressing clinical characteristics, comorbidity, course, and treatment.
- Grand Rounds
- Mood Disorders
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
01/31/2024
$0.00
Many patients with depression cannot be brought into a state of sustained symptom remission. Sometimes called “treatment resistant” depression, they may be better understood as “difficult to treat depressions” (DTD) because this clinical heuristic promotes the search for treatable pharmacological, psychosocial, and biological/medical obstacles to achieving or sustaining remission. Furthermore, the DTD heuristic recognizes that some depressions may be better managed by optimizing symptom control, quality of life, and daily function, rather than by conducting multiple revisions in treatment from which little, longer-term benefit may be expected. The clinical challenges (e.g., selecting assessments for treatable causes; identifying treatment sequences for specific patients) as well as the research challenges (e.g., defining types of DTD; assessing outcomes) are discussed.
- Grand Rounds
- Mood Disorders
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
02/07/2024
$0.00
“Treatment resistant depression (TRD)” is defined when a patient’s depression has failed to respond to two consecutive adequate trails of different antidepressants. This begs the question as to who or what is “resistant”. TRD focuses on non-response, does not take into account the equally challenging situations of lack of a sustained response or intolerance/contraindication/non-acceptance of treatment. “Difficult-to-treat depression (DTD)” is an alternative, more clinically orientated, concept of depression with poor outcomes. It describes depression that continues to cause a burden to the patient despite usual treatment efforts by the clinician. Most importantly, DTD is associated with a chronic, rather than acute, illness model of care. Key to this is holistic, individualised, management identifying factors that may contribute to the poor outcome and which may be tractable. While remission of symptoms is the primary goal of treatment, if this is difficult to achieve, the focus might more appropriately shift towards optimal management of residual symptoms and most importantly improvement in psychosocial functioning and quality of life. This presentation will discuss how to manage DTD systematically using the DTD model of care to optimize not only symptomatic improvement of patients, but also reducing risks of relapse and maximizing improvements in patient’s quality of life.